The results showed that high expression of CDCA3 was associated with poor outcomes in HCC patients, and it could act as a potential independent predictor of survival (HR = 2.037; 95%CI = 1.484–2.796; p < 0.001; Figure 3(d)) by excluding confounding factors. This evidence concerns the gene CDCA3 and hepatocellular carcinoma.